CV/COS Webinar: Clip 16

During the insightful discussion, the potential use of real-world data for a synthetic control arm in clinical trials was explored. Carevive’s commitment to adhering to regulatory standards for electronic data capture sets a strong foundation for future opportunities in optimizing this data for regulatory interactions. While no definitive commitments can be made, the increasing patient numbers and rigorous methods prioritized by Carevive offer hope for real-world data to play a significant role in regulatory decision-making. Collaborating with Aaron and his team, Carevive aims to contribute to the advancement of oncology research and elevate patient outcomes through the integration of real-world evidence.

Recent Episodes

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

In “Fighting for Coverage,” a patient describes a double war: the physical fight to stay alive and the bureaucratic fight to prove to an insurer that her life is worth the cost. Her account spotlights a core tension in the U.S. system—coverage decisions are increasingly shaped by prior authorizations and desk-based reviewers who…

The sustainability of the healthcare system won’t be secured by another round of cost-cutting or clever benefit design alone, but by a hard cultural pivot toward alignment: payers, providers, employers, and patient advocates pulling on the same rope instead of grading each other on different exams. Right now we’ve built a maze that…